The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further investment in Pressfit Holdings Plc

1 Jun 2012 07:00

RNS Number : 5862E
Craven House Capital PLC
01 June 2012
 



1 June 2012

 

CRAVEN HOUSE CAPITAL PLC

("Craven House" or the "Company")

 

Further investment in Pressfit Holdings Plc

 

The Company are today pleased announced that on 31 May 2012, it had agreed to purchase 10,093,556 shares in Pressfit Holdings Plc ("Pressfit") (representing approximately 32.5 per cent. of the Company's issued share capital) from existing shareholders at 12.84p per share, amounting to an aggregate consideration of circa £1.3 million. This purchase of shares is conditional upon the shareholders subscribing for 103,963,626 new ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") for 1.25p per share, equating to an aggregate subscription of approximately £1.3 million. This investment follows the Company's previous investments into Pressfit in September 2011 and January 2011. Craven House now owns 36.9 per cent, in aggregate, of Pressfit with a further 3 per cent. of the share capital of Pressfit available to Craven House, should Craven House choose to convert the outstanding convertible loan made to Pressfit in September 2011.

 

Pressfit is an unquoted UK public limited company with Hong Kong and Chinese subsidiaries, which utilises proprietary technology to manufacture high-precision, thin walled stainless steel and carbon steel pipes and fittings used for plumbing and heating applications in the commercial, residential, industrial and agricultural sectors. Distribution of these products is tightly controlled by rigorous certification standards, which vary according to jurisdiction. Pressfit has successfully obtained the appropriate certification to distribute its products into the UK, the EU, Hong Kong, China and Macau. It expects to receive its US certification imminently.

 

Given these certification standards and the complexity of production methods, the global market for press-fittings is controlled by a very small number of participants. Pressfit's principal competitors manufacture in Europe, providing Pressfit the advantage of a much lower cost-base. In addition, Pressfit is the only manufacturer in China who currently possesses the technology required to produce press-fittings and has obtained the required certification to distribute its products into Western markets. Pressfit has received initial orders from distributors in the UK, EU and Hong Kong since September 2011 and the Company's directors believe that Pressfit is extremely well placed to make inroads into the market for these products, which is worth hundreds of millions of dollars per year and growing.

 

Mark Pajak, Acting Chairman, commented, "We are very pleased to be able to report Craven House's largest, and possibly its most exciting, investment to date as we take a significant stake in Pressfit Holdings.

 

This follows our most recent visit to Pressfit's facility in Shandong in March 2012. We are very impressed with the efficiency and professionalism of the management team, as well as the quality of the facilities and manufacturing techniques and, most importantly, the breadth and quality of the Pressfit product line.

 

We believe that Pressfit is poised to acquire a substantial market share in this growing segment of a multi billion-dollar industry. The confluence of very high specification manufacturing that meets the rigorous standards of the international governing bodies' certification process and the low cost production is a rare and valuable combination. We believe Pressfit has the potential to achieve high margins while offering customers a more competitively priced product. We believe this sets the stage for rapid growth of both revenue and profits. We applaud the management and engineers at Pressfit for its rapid development.

 

We are very pleased to have secured this investment utilising our shares as currency - a clearly defined and central aspect of our investment strategy, with the Company's shares again valued at 1.25p per share. Craven House's continued ability to secure transactions which value its shares at a premium to the current market price, such as the previous investments in Pressfit and the recent $801,892.50 investment in Farm Lands of Africa (Ticker: FLAF.OB), reinforce our belief in Craven House's future growth prospects. We continue to seek opportunities where we can leverage our knowledge and capital market experience to the advantage of portfolio companies and Craven House shareholders.

Craven House is now Pressfit's largest shareholder and we look forward to continuing to work closely with management as a long-term strategic shareholder and supporting this company further as they deliver on their plans for expansion."

 

Further information about Pressfit can be found at http://pressfitholdings.com/.

 

Application is being made to the London Stock Exchange for the new Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on Monday 11 June 2012. The shares will rank pari passu with the existing issued ordinary shares.

 

Following the issue of the new ordinary shares, the Company's total issued share capital will consist of 435,145,221 ordinary shares with each share carrying the right to one vote. The Company has no ordinary shares held in treasury. The total of 435,145,221 ordinary shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSDIFWFFESELI
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.